News
A new study by Indiana University School of Medicine researchers has revealed a breakthrough in the fight against acute ...
In a new study published in Cancer Immunology Research, scientists at the Icahn School of Medicine at Mount Sinai have ...
4h
News Medical on MSNNew drug strategy blocks cancer cells' adaptation, doubling chemotherapy effectiveness
In a wholly new approach to cancer treatment, Northwestern University biomedical engineers have doubled the effectiveness of ...
21h
News-Medical.Net on MSNRadiation primes the immune system to attack lung tumors resistant to immunotherapy
By sparking the immune system into action, radiation therapy makes certain tumors that resist immunotherapy susceptible to ...
2d
News-Medical.Net on MSNMicrobial signals rewire immunity in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is a deadly cancer with particularly high prevalence in East Asia. While ...
In a breakthrough study published in Cancer Immunology Research , scientists at the Icahn School of Medicine at Mount Sinai have developed a novel ...
A stage-four cancer diagnosis once sounded like the end of the road – after all, there is no stage five. When Joe Biden’s ...
Cancer-fighting immune cells in patients with lung cancer whose tumors do not respond to immunotherapies appear to be running on a different 'program' that makes them less effective than immune ...
Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body's ...
Glioblastoma is widely considered the deadliest form of brain cancer, killing over 10,000 Americans each year.
New tool reveals disruption of immune cells in blood is linked to cancer outcomes. ScienceDaily. Retrieved June 11, 2025 from www.sciencedaily.com / releases / 2025 / 02 / 250218113823.htm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results